Non‑alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism

Simple item page
dc.centroFacultad de Medicinaes_ES
dc.contributor.authorCornejo Pareja, Isabel María
dc.contributor.authorMohamed-Reda, Amiar
dc.contributor.authorOcaña-Wilhelmi, Luis Tomás
dc.contributor.authorSoler Humanes, Rocio
dc.contributor.authorArranz-Salas, Isabel María
dc.contributor.authorGarrido-Sánchez, Lourdes
dc.contributor.authorGutiérrez-Repiso, Carolina
dc.contributor.authorTinahones-Madueño, Francisco José
dc.date.accessioned2024-01-30T08:28:20Z
dc.date.available2024-01-30T08:28:20Z
dc.date.issued2024-01-24
dc.departamentoIBIMA. Instituto de Investigación Biomédica de Málaga
dc.description.abstractAlterations in gut microbiota are associated with the pathogenesis of metabolic diseases, including metabolic-associated fatty liver disease (MAFLD). The aim of this study was to evaluate gut microbiota composition and functionality in patients with morbid obesity with different degrees of MAFLD, as assessed by biopsy.es_ES
dc.description.sponsorshipFunding for open Access charge: Universidad de Málaga / CBUA. This work was supported in part by a grant from the Ministry of Health and Families of Junta de Andalucía (PI-0108-2022). (“A way to make Europe”). This study was co-funded by FEDER funds. I.C.-P. was the recipient of a postdoctoral grant (Río Hortega CM 17/00169), and is now the recipient of a post-doctoral grant (Juan Rodes JR 19/00054) from the Instituto de Salud Carlos III and co-funded by Fondo Europeo de Desarrollo Regional-FEDER. L.G.-S. is supported by the Nicolas Monardes program from Consejería de Salud de Andalucía (Spain) (C-0028-2018). C.G.-R. was supported by the Miguel Servet program from the Instituto de Salud Carlos III (CP20/00066).es_ES
dc.identifier.citationCornejo-Pareja, I., Amiar, M.R., Ocaña-Wilhelmi, L. et al. Non-alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism. J Gastroenterol (2024). https://doi.org/10.1007/s00535-023-02075-7es_ES
dc.identifier.doi10.1007/s00535-023-02075-7
dc.identifier.urihttps://hdl.handle.net/10630/29349
dc.language.isospaes_ES
dc.publisherSpringer Naturees_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.accessRightsopen accesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectHígado - Enfermedadeses_ES
dc.subjectMetabolismo - Alteracioneses_ES
dc.subjectObesidades_ES
dc.subjectHepatitises_ES
dc.subject.otherMetabolic-associated fatty liver disease (MAFLD)es_ES
dc.subject.otherNon-alcoholic steatohepatitis (NASH)es_ES
dc.subject.otherHepatic steatosises_ES
dc.subject.otherGut microbiota pattern composition and functionalityes_ES
dc.subject.otherMorbid obesityes_ES
dc.titleNon‑alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanismes_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicationeef74b46-b388-4d91-b92f-c24b0175e22c
relation.isAuthorOfPublication3ad83f2e-8a84-4c8f-b6b9-c195f9bf9049
relation.isAuthorOfPublication5008638f-787f-4d12-81ea-8f34216949a5
relation.isAuthorOfPublication.latestForDiscoveryeef74b46-b388-4d91-b92f-c24b0175e22c

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
s00535-023-02075-7.pdf
Size:
1.4 MB
Format:
Adobe Portable Document Format
Description:
Download

Collections

Artículos